We next performed similar experiments in additional NSCLC cell lines encompassing a wider range of driver mutations found in human LUAD, including KRAS, EGFR and BRAF, as well as cells without known driver mutations in the ERK-pathway, (WT). This evidence concerns the gene BRAF and non-small cell lung carcinoma.